Abnormal Uterine Bleeding: Medical Treatment with Vaginal Danazol and Five-Year Follow-up
article
OA: closed
CC0
⤵ 8 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated the efficacy of vaginal danazol for abnormal uterine bleeding and followed patients for five years to assess treatment outcomes.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (18)
- A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia via openalex
- Clinical effects of danazol on endometrial hyperplasia in menopausal and postmenopausal women via openalex
- Comparison between mefenamic acid and danazol in the treatment of established menorrhagia via openalex
- Danazol for heavy menstrual bleeding via openalex
- Danazol for heavy menstrual bleeding via openalex
- Influence of vaginal danazol on uterine and brain perfusion during hormonal replacement therapy via openalex
- Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up via openalex
- Nafarelin for endometriosis: A large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up via openalex
- REDUCTION OF MENSTRUAL BLOOD LOSS BY DANAZOL IN UNEXPLAINED MENORRHAGIA: LACK OF EFFECT OF PLACEBO via openalex
- doi:10.1016/s0002-9378(96)80086-x via openalex
- doi:10.1002/(sici)1097-0142(19970115)79:2<320::aid-cncr15>3.0.co;2-2 via openalex
- doi:10.1016/s0304-3835(01)00462-1 via openalex
- W30149722 via openalex
- W2402069359 via openalex
- W2444627600 via openalex
- W6601229071 via openalex
- doi:10.1016/s0306-5456(01)00275-3 via openalex
- doi:10.1111/j.1471-0528.2001.00275.x via openalex
Cited by (8)
- Long-Term Vaginal Danazol Treatment in Fertile Age Women with Adenomyosis 2017
- Adenomyosis: a systematic review of medical treatment 2016
- Comparative study of vaginal danazol vs diphereline (a synthetic GnRH agonist) in the control of bleeding during hysteroscopic myomectomy in women with abnormal uterine bleeding: a randomized controlled clinical trial 2015
- Vaginally Administered Danazol: An Overlooked Option in the Treatment of Rectovaginal Endometriosis? 2015
- Future developments in the medical treatment of abnormal uterine bleeding 2011
- Hémorragies utérines fonctionnelles ou ménorragies idiopathiques 2008
- Efficacy of vaginal danazol treatment in women with menorrhagia during fertile age 2008
- Intravaginal oestrogen and progestin administration: advantages and disadvantages 2007
Source provenance
- openalex
- last seen: 2026-05-11T06:03:29.626429+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK